Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 321,546 shares at $74.11 ($24.2M) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Seasonal sale ($24.2M) by Chief Executive Officer — this insider has traded IONS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.11 | 7,382 | $547K | 2.3% |
| 2 | $74.11 | 7,382 | $547K | 2.3% |
| 3 | $75.26 | 117,604 | $8.9M | 36.5% |
| 4 | $75.26 | 117,604 | $8.9M | 36.5% |
| 5 | $75.58 | 1,684 | $127K | 0.5% |
| 6 | $75.58 | 1,684 |
| $127K |
| 0.5% |
| 7 | $75.47 | 16,512 | $1.2M | 5.1% |
| 8 | $75.47 | 16,512 | $1.2M | 5.1% |
| 9 | $76.34 | 17,591 | $1.3M | 5.5% |
| 10 | $76.34 | 17,591 | $1.3M | 5.5% |
| Total | $75.35 avg | 321,546 | $24.2M | 100% |
| Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |
| IONS | SELL | 2026-01-20 | $3.3M | — | Filing → |